论文部分内容阅读
Purpose:To evaluate the performance of quantitative EASL(qEASL),a volumetric enhancement criterion,to assess tumor response and predict overall survival(OS)in patients with hepatocellular carcinoma(HCC)treated using conventional transarterial chemoembolization(cTACE),compared to existing 1-and 2-dimensional methods(RECIST,mRECIST,EASL)on computed tomography(CT)scans.